PCSK9 and fetal growth restriction: Previous studies showed that PCSK9 concentrations in cord blood or the serum of high-risk neonates (ie, neonates born premature, with intrauterine growth restriction, or small or large for gestational age [GA]) differ significantly compared with neonates born at term, without growth restriction, or with appropriate birth weight for GA [12-14].